NUTAC
A new approach to therapeutic antibodies
  • Print
   
   

Research

The Centre consists of a number of inter-related research teams covering a range of disciplines.

Postgraduate student working in a clinical sciences lab
 

The oncology group aims to develop new treatments to target cancer by focusing at the interface between laboratory and clinical research. The generation of anti-glycan mAbs and their ability to induce rapid tumour cell death makes them ideal cancer therapeutics. Members of the group researching infectious disease agents are seeking unique approaches to combat pathogenic strains of community associated MRSA by utilising therapeutic, toxin-neutralising mAbs. 

Alongside the investment from the University, oncology research in the Centre is supported by:

Cancer Research UK logo

Pancreatic Cancer Research Fund

Lewis Family Charitable Trust logo

NUTAC

Department of Clinical Oncology
City Hospital
Hucknall Road, Nottingham, NG5 1PB

telephone: +44 (0) 115 82 31863